NewGenIvf Enhances IVF Services Through Acquisition of MicroSort Technology
January 21, 2025 - 14:05
NewGenIvf has made a significant move to expand its in vitro fertilization (IVF) capabilities by acquiring the MicroSort gender selection technology in a strategic deal valued at $5 million. This acquisition not only enhances NewGenIvf's service offerings but also brings proven sperm-sorting technology into its portfolio, which has been successfully utilized in various regions across Asia.
The deal is structured with a cash component of $750,000, alongside an equity component, reflecting the company's commitment to integrating advanced reproductive technologies. MicroSort's existing licenses and expertise in gender selection are expected to bolster NewGenIvf's position in the competitive IVF market, allowing it to provide more personalized reproductive options for couples seeking to conceive.
With this acquisition, NewGenIvf aims to lead the way in innovative reproductive health solutions, catering to the growing demand for gender selection and enhancing the overall patient experience in fertility treatments. This strategic investment marks a notable milestone in the company's growth trajectory.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...